Efficacy and safety of a low-molecular-weight heparin and standard unfractionated heparin for prophylaxis of postoperative venous thromboembolism: European multicenter trial

World Journal of Surgery

Volumn 21, Issue 1, 1997, Pages 2-9

  Kakkar, V V ⁿ   Boeckl, O ^c   Boneu, B ^e   Bordenave, L ^g   Brehm, O A ^d   Brücke, Peter ^a   Coccheri, S ^o   Cohen, A T ^o   Galland, F ^f   Haas, S ^o   Jarrige, J ⁱ   Koppenhagen, K ^l   LeQuerrec, A ^h   Parraguette, E ^j   Prandoni, P ^o   Roder, J D ^o   Roos, M ^k   Ruschemeyer C ^o   Siewert, J R ^o   Vinazzer, H ^b   Wenzel, E ^m   more..

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b Blood Coagulation Laboratory   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d UNIV KLIN FÜR FRAUENHEILKUNDE   (Austria)

^e Laboratoire d'Hemostase   (France)

^f Lab de Physiol et d'Explor Fonct   (France)

^g UNIVERSITÉ DE BORDEAUX   (France)

^h Laboratoire d'Hématologies   (France)

ⁱ Départ d'Anésthesiol   (France)

^j CHU PURPAN   (France)

^k Toulouse Rangueil   (France)

^l FREIE UNIVERSITÄT BERLIN   (Germany)

^m SAARLAND UNIVERSITY   (Germany)

ⁿ THROMBOSIS RESEARCH INSTITUTE   (United Kingdom)

^o NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR 10A INHIBITOR; FIBRINOGEN; GAMMA GLUTAMYLTRANSFERASE; HEMOGLOBIN; HEPARIN; LACTATE DEHYDROGENASE; LOW MOLECULAR WEIGHT HEPARIN; REVIPARIN; THROMBIN; THROMBOPLASTIN; TRIACYLGLYCEROL;

ABDOMINAL SURGERY; ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; EUROPE; FEMALE; GOOD CLINICAL PRACTICE; HEMATOMA; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POSTOPERATIVE THROMBOSIS; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOEMBOLISM; THROMBOSIS PREVENTION; TREATMENT OUTCOME;

EID: 0031013428     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002689900185     Document Type: Article

References (23)

1. Barrowcliffe, T.W., Johnson, E.A., Thomas, D.P.; Low Molecular Weight Heparin. New York, Wiley, 1992
2. Kakkar, V.V., Djazaeri, B., Fok, J., Fletcher, M., Scully, M.F., Westwick, J.: Low molecular weight heparin in the prophylaxis of venous thrombosis. B.M.J. 284:375, 1982
3. Esquivel, C.O., Bergqvist, D., Bjork, C-G., Nilsson, B.; Comparison between commercial heparin, low molecular weight heparin and pentosan polysulphate on haemostasis and platelets in vivo. Thromb. Res. 28:389, 1982
4. Carter, C.J., Kelton, J.G., Hirsh, J., Cerskus, A.L., Santos, A.V., Gent, M.: The relationship between the haemorrhagic and antithrombotic properties of low molecular weight heparins and heparin. Blood 59:1239, 1982
5. Bristol, D.R.: Sample sizes for constructing confidence intervals and testing hypotheses. Stat. Med. 8:803, 1989
6. SNOMED, Systematized Nomenclature of Medicine (2nd ed.). Philadelphia, College of American Pathologists, 1979
7. 125I-fibrinogen test adopted for routine screening. Lancet 1:540, 1970
8. Jesperson, J., Bertina, R.M., Haverkate, F., Luwer, K.: ECAT Assay Procedures: A Manual of Laboratory Techniques. London, Academic, 1992, p. 230
9. Fleiss, J.L.: Statistical Methods for Rates and Proportions (2nd ed.) New York, Wiley, 1981
10. Kakkar, V.V., Howe, G.T., Nicolaides, A.N., Renney, J.T.G., Clarke, M.B.: Deep vein thrombosis of the leg: is there a "high-risk" group. Ann. Surg. 120:527, 1970
11. Kakkar, V.V., Cohen, A.T., Edmondson, R.A., Phillips, M.J., Cooper, D.J., Das. S.K., Maher, K.T., Sanderson, R.M., Ward, V.P., Kakkar, S.; Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. Lancet 341:259, 1993
12. Bara, L., Leizorovicz, A., Picolet, H., Samama, M.: Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Thromb. Res. 65:641, 1992
13. Levine, M.N., Planes, A., Hirsh, J., Goodyear, M., Vochelle, N., Gent, M.: The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacement. Thromb. Haemost. 62:940, 1989
14. Olivcrona, T., Bengtsson-Olivkrona, G.: Heparin and upases. In: Heparin, Chemical and Biological Properties; Clinical Applications, D.A. Lane, U. Lindahl, editors. London, Edward Arnold, 1989. pp. 335-362
15. Greten, H., Walter, B., Brown, W.V.; Purification of a human post-heparin plasma triglyceride lipase. FEBS Lett, 27:306, 1972
16. Thomas, D.P., Merton, R.E., Lewis, W.E., Barrowcliffe, T.W.: Studies in man and experimental animals of a low molecular weight heparin fraction. Thromb. Haemost. 45:214, 1981
17. Pescador, R., Porton, R., Niada, R., Diamantini, G., Fedeli, G., Mantovani, M.: The anticoagulant, hepatic lipase-releasing and lipoprotein lipase-releasing activities of several natural and chemicallymodified heparins differ. Biochem. Pharmacol. 36:253, 1987
18. Bendetowicz, A.V., Beguin, S., Caplan, H., Hemker, H.C.: Pharmacokinetics and pharmacodynamics of a low molecular weight heparin (Enoxaparin) after subcutaneous injection: comparison with unfractionated heparin - a three way cross-over study in human volunteers. Thromb. Haemost. 71:305, 1994
19. Leizorovicz, A., Haugh, M.C., Chapuis, F.R., Samama, M.M., Joissel, J-P.: Low molecular weight heparin in prevention of peri-operative thrombosis. B.M.J. 305:913, 1992
20. Nurmohamed, M.T., Rosendaal, F.R., Büller, H.R., Dekker, E., Hommes, D.W., Vandenbroncke J.P., Briet, E.: The efficacy and safety of low molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 340:152, 1992
21. Lassen, M.R., Borris, L.C., Christiansen, H.M., Schøtt, P., Olsen, A.D., Sørensen, J.V., Rahr, H., Jensen, H.P.: Clinical trials with low molecular weight heparin in the prevention of post-operative thromboembolic complications: a meta-analysis. Semin. Thromb. Hemost. 17(Suppl. 3):284, 1991
22. Kakkar, V.V.: Efficacy and safety of Clivarin and other LMWHs in general surgery: a meta-analysis: Blood Coag. Fibrin. 4(Suppl. 1):S23, 1993
23. International Multicentre Trial: Prevention of postoperative pulmonary embolism by low doses of heparin. Lancet 2:45, 1975